Characteristics of surviving patients of the LERIC cohort
| Participants (n=126) | Non-participants (n=61) | |
|---|---|---|
| *RRT, renal replacement therapy; †including focal segmental glomerulosclerosis, rapidly progressive glomerulonephritis, membranoproliferative glomerulonephritis; ‡including reflux uropathy, urethal valves, neurogenic bladder, Prune Belly syndrome; §including polycystic disease, nephronophtisis, dysplasia. | ||
| Gender: male/female | 70/56 | 33/28 |
| Primary disease: | ||
| Glomerulonephritis† | 45 (36%) | 19 (31.1%) |
| Interstitial nephritis/obstructive uropathy‡ | 39 (31.2%) | 16 (26.2%) |
| Congenital kidney diseases§ | 23 (17.6%) | 18 (29.5%) |
| Haemolytic uraemic syndrome | 10 (8.0%) | 5 (8.2%) |
| Cystinosis, oxalosis, and SLE | 4 (3.2%) | 10 (16.1%) |
| Other | 8 (6.4%) | 3 (4.9%) |
| Unknown | 1 (0.8%) | 0 |
| Mean age of start RRT* in years (SD) | 10.8 (2.9) | 11.0 (3.0) |
| Mean age at time of investigation in years (SD) | 29.4 (5.2) | 29.5 (5.3) |
| Mean duration of RRT* in years (SD) | 18.2 (5.3) | 18.3 (5.1) |
| Mean duration of dialysis in years (SD) | 4.1 (4.6) | 4.2 (4.4) |
| Mean duration of functioning renal graft in years (SD) | 14.0 (6.4) | 14.1 (5.6) |
| On dialysis at time of investigation (n) | 28 (22.2%) | 13 (21.3%) |